Leuprolide-induced myopathy [1]

Journal of the American Geriatrics Society

Volumn 50, Issue 10, 2002, Pages 1746-

  Van Gerpen, Jay A ^a   McKinley, Kevin L ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; GONADORELIN; LEUPRORELIN;

AGED; CANCER HORMONE THERAPY; CASE REPORT; DRUG INDUCED DISEASE; GERIATRIC PATIENT; HUMAN; LETTER; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; PROSTATE CARCINOMA; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; CREATINE KINASE; HUMANS; LEUPROLIDE; MALE; MUSCULAR DISEASES;

EID: 18644385065     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2002.50474.x     Document Type: Letter

References (6)

1. Pascuzzi RM. Drugs and toxins associated with myopathies. Curr Opin Rheumatol 1998;10:511-520.
2. Victor M, Sieb JP. Myopathies due to drugs, toxins, and nutritional deficiency. In: Engel AG, Franzini-Armstrong C, eds. Myology, 2nd Ed. New York, NY: McGraw-Hill, 1994, pp 1697-1725.
3. Crayton H, Bohlmann T, Sufit R et al. Drug induced polymyositis secondary to leuprolide acetate (Lupton) therapy for prostate carcinoma. Clin Exp Rheumatol 1991;9:525-528.
4. Physicians Desk Reference, 56th Ed. Montvale, NJ: Medical Economics Company, 2002, pp 3279-3292.
5. Cook T, Sheridan WP. Development of GnRH antagonists for prostate cancer: New approaches to treatment. Oncologist 2000;5:162-168.
6. Orrell RW, Woodrow DF, Barrett MC et al. Testosterone-deficient myopathy. J R Soc Med 1995;88:454-456.